1-6 of 6
Authors: Qing Zhu
Journal Article
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Get access
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages 394–402, https://doi.org/10.1093/infdis/jiae192
Published: 08 May 2024
Journal Article
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019
The Journal of Infectious Diseases, Volume 222, Issue 2, 15 July 2020, Pages 189–193, https://doi.org/10.1093/infdis/jiaa243
Published: 08 May 2020
Journal Article
Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897
The Journal of Infectious Diseases, Volume 218, Issue 4, 15 August 2018, Pages 572–580, https://doi.org/10.1093/infdis/jiy189
Published: 30 March 2018
Journal Article
The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
The Journal of Infectious Diseases, Volume 216, Issue 3, 1 August 2017, Pages 356–365, https://doi.org/10.1093/infdis/jix292
Published: 17 June 2017
Journal Article
Natural Polymorphisms and Resistance-Associated Mutations in the Fusion Protein of Respiratory Syncytial Virus (RSV): Effects on RSV Susceptibility to Palivizumab Get access
The Journal of Infectious Diseases, Volume 205, Issue 4, 15 February 2012, Pages 635–638, https://doi.org/10.1093/infdis/jir790
Published: 19 December 2011
Journal Article
Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab Get access
The Journal of Infectious Diseases, Volume 203, Issue 5, 1 March 2011, Pages 674–682, https://doi.org/10.1093/infdis/jiq100
Published: 05 January 2011
